Dengue virus nonstructural protein 1-induced antibodies cross-react with human plasminogen and enhance its activation

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1218-1226

  Chuang, Yung Chun ^a   Lin, Jessica ^a   Lin, Yee Shin ^a   Wang, Shuying ^a   Yeh, Trai Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1; PLASMINOGEN; SERINE PROTEINASE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS; ENZYME ACTIVITY; EPITOPE MAPPING; FEMALE; FIBRINOLYSIS; HEMOSTASIS; IMMUNOREACTIVITY; MOLECULAR MIMICRY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; ANIMAL; BAGG ALBINO MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CROSS REACTIONS; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FIBRINOLYSIS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; PLASMINOGEN; SEVERE DENGUE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84957671076     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500057     Document Type: Article

References (47)

1. Guzman, M. G., S. B. Halstead, H. Artsob, P. Buchy, J. Farrar, D. J. Gubler, E. Hunsperger, A. Kroeger, H. S. Margolis, E. Martínez, et al. 2010. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8(Suppl 12.): S7-S16.
2. Bhatt, S., P. W. Gething, O. J. Brady, J. P. Messina, A. W. Farlow, C. L. Moyes, J. M. Drake, J. S. Brownstein, A. G. Hoen, O. Sankoh, et al. 2013. The global distribution and burden of dengue. Nature 496: 504-507.
3. Narvaez, F., G. Gutierrez, M. A. Pérez, D. Elizondo, A. Nun-ez, A. Balmaseda, and E. Harris. 2011. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl. Trop. Dis. 5: e1397.
4. Mairuhu, A. T., M. R. Mac Gillavry, T. E. Setiati, A. Soemantri, H. ten Cate, D. P. Brandjes, and E. C. van Gorp. 2003. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect. Dis. 3: 33-41.
5. Chuansumrit, A., and W. Chaiyaratana. 2014. Hemostatic derangement in dengue hemorrhagic fever. Thromb. Res. 133: 10-16.
6. Wills, B., V. N. Tran, T. H. Nguyen, T. T. Truong, T. N. Tran, M. D. Nguyen, V. D. Tran, V. V. Nguyen, T. T. Dinh, and J. Farrar. 2009. Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. Am. J. Trop. Med. Hyg. 81: 638-644.
7. Kuhn, R. J., W. Zhang, M. G. Rossmann, S. V. Pletnev, J. Corver, E. Lenches, C. T. Jones, S. Mukhopadhyay, P. R. Chipman, E. G. Strauss, et al. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725.
8. Muller, D. A., and P. R. Young. 2013. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 98: 192-208.
9. Mackenzie, J. M., M. K. Jones, and P. R. Young. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232-240.
10. Jacobs, M. G., P. J. Robinson, C. Bletchly, J. M. Mackenzie, and P. R. Young. 2000. Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB J. 14: 1603-1610.
11. Avirutnan, P., A. Fuchs, R. E. Hauhart, P. Somnuke, S. Youn, M. S. Diamond, and J. P. Atkinson. 2010. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J. Exp. Med. 207: 793-806.
12. Avirutnan, P., R. E. Hauhart, P. Somnuke, A. M. Blom, M. S. Diamond, and J. P. Atkinson. 2011. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 187: 424-433.
13. Lin, S. W., Y. C. Chuang, Y. S. Lin, H. Y. Lei, H. S. Liu, and T. M. Yeh. 2012. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J. Infect. 64: 325-334.
14. Cheng, H. J., H. Y. Lei, C. F. Lin, Y. H. Luo, S. W. Wan, H. S. Liu, T. M. Yeh, and Y. S. Lin. 2009. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation. Mol. Immunol. 47: 398-406.
15. Cheng, H. J., Y. H. Luo, S. W. Wan, C. F. Lin, S. T. Wang, N. T. Hung, C. C. Liu, T. S. Ho, H. S. Liu, T. M. Yeh, and Y. S. Lin. 2015. Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients. Am. J. Trop. Med. Hyg. 92: 989-995.
16. Sun, D. S., Y. C. Chang, T. S. Lien, C. C. King, Y. L. Shih, H. S. Huang, T. Y. Wang, C. R. Li, C. C. Lee, P. N. Hsu, and H. H. Chang. 2015. Endothelial cell sensitization by death receptor fractions of an anti-dengue nonstructural protein 1 antibody induced plasma leakage, coagulopathy, and mortality in mice. J. Immunol. 195: 2743-2753.
17. Stassen, J. M., J. Arnout, and H. Deckmyn. 2004. The hemostatic system. Curr. Med. Chem. 11: 2245-2260.
18. Huang, Y. H., C. C. Liu, S. T. Wang, H. Y. Lei, H. L. Liu, Y. S. Lin, H. L. Wu, and T. M. Yeh. 2001. Activation of coagulation and fibrinolysis during dengue virus infection. J. Med. Virol. 63: 247-251.
19. Sosothikul, D., P. Seksarn, S. Pongsewalak, U. Thisyakorn, and J. Lusher. 2007. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb. Haemost. 97: 627-634.
20. Markoff, L. J., B. L. Innis, R. Houghten, and L. S. Henchal. 1991. Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection. J. Infect. Dis. 164: 294-301.
21. Chuang, Y. C., H. Y. Lei, Y. S. Lin, H. S. Liu, H. L. Wu, and T. M. Yeh. 2011. Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. J. Immunol. 187: 6483-6490.
22. Lin, Y. S., T. M. Yeh, C. F. Lin, S. W. Wan, Y. C. Chuang, T. K. Hsu, H. S. Liu, C. C. Liu, R. Anderson, and H. Y. Lei. 2011. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. (Maywood) 236: 515-523.
23. Chuang, Y. C., Y. S. Lin, H. S. Liu, J. R. Wang, and T. M. Yeh. 2013. Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities. Thromb. Haemost. 110: 358-365.
24. Chungue, E., L. Poli, C. Roche, P. Gestas, P. Glaziou, and L. J. Markoff. 1994. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J. Infect. Dis. 170: 1304-1307.
25. Chuang, Y. C., Y. S. Lin, H. S. Liu, and T. M. Yeh. 2014. Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis. J. Virol. 88: 13759-13768.
26. Rai, C. I., H. Y. Lei, Y. S. Lin, H. S. Liu, S. H. Chen, L. C. Chen, and T. M. Yeh. 2008. Epitope mapping of dengue-virus-enhancing monoclonal - Antibody using phage display peptide library. Am. J. Infect. Dis. 7: 76-84.
27. Akey, D. L., W. C. Brown, S. Dutta, J. Konwerski, J. Jose, T. J. Jurkiw, J. DelProposto, C. M. Ogata, G. Skiniotis, R. J. Kuhn, and J. L. Smith. 2014. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343: 881-885.
28. Law, R. H., T. Caradoc-Davies, N. Cowieson, A. J. Horvath, A. J. Quek, J. A. Encarnacao, D. Steer, A. Cowan, Q. Zhang, B. G. Lu, et al. 2012. The X-ray crystal structure of full-length human plasminogen. Cell Reports 1: 185-190.
29. Wootla, B., S. Lacroix-Desmazes, A. E. Warrington, A. J. Bieber, S. V. Kaveri, and M. Rodriguez. 2011. Autoantibodies with enzymatic properties in human autoimmune diseases. J. Autoimmun. 37: 144-150.
30. Gololobov, G. V., S. V. Mikhalap, A. V. Starov, A. F. Kolesnikov, and A. G. Gabibov. 1994. DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl. Biochem. Biotech. 47: 305-314; discussion 314-315.
31. Ponomarenko, N. A., O. M. Durova, I. I. Vorobiev, E. S. Aleksandrova, G. B. Telegin, O. G. Chamborant, L. L. Sidorik, S. V. Suchkov, Z. S. Alekberova, N. V. Gnuchev, and A. G. Gabibov. 2002. Catalytic antibodies in clinical and experimental pathology: human and mouse models. J. Immunol. Methods 269: 197-211.
32. Lacroix-Desmazes, S., A. Moreau, C. Sooryanarayana, C. Bonnemain, N. Stieltjes, A. Pashov, Y. Sultan, J. Hoebeke, M. D. Kazatchkine, and S. V. Kaveri. 1999. Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med. 5: 1044-1047.
33. Mahendra, A., M. Sharma, D. N. Rao, I. Peyron, C. Planchais, J. D. Dimitrov, S. V. Kaveri, and S. Lacroix-Desmazes. 2013. Antibody-mediated catalysis: induction and therapeutic relevance. Autoimmun. Rev. 12: 648-652.
34. Lähteenmäki, K., S. Edelman, and T. K. Korhonen. 2005. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13: 79-85.
35. Sun, H. 2006. The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 21: 281-288.
36. Dominguez, M., R. Montes, J. A. Páramo, and E. Anglés-Cano. 2002. Bivalency of plasminogen monoclonal antibodies is required for plasminogen bridging to fibrin and enhanced plasmin formation. Biochim. Biophys. Acta 1598: 165-176.
37. Chen, M. C., C. F. Lin, H. Y. Lei, S. C. Lin, H. S. Liu, T. M. Yeh, R. Anderson, and Y. S. Lin. 2009. Deletion of the C-terminal region of dengue virus non-structural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J. Immunol. 183: 1797-1803.
38. Wan, S. W., Y. T. Lu, C. H. Huang, C. F. Lin, R. Anderson, H. S. Liu, T. M. Yeh, Y. T. Yen, B. A. Wu-Hsieh, and Y. S. Lin. 2014. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS One 9: e92495.
39. Yang, Y. H., C. J. Chang, Y. H. Chuang, H. Y. Hsu, P. P. Chen, and B. L. Chiang. 2010. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity. Rheumatology (Oxford) 49: 34-42.
40. Guzman, M. G., and E. Harris. 2015. Dengue. Lancet 385: 453-465.
41. Martina, B. E., P. Koraka, and A. D. Osterhaus. 2009. Dengue virus pathogen-esis: an integrated view. Clin. Microbiol. Rev. 22: 564-581.
42. Thomas, S. J. 2015. NS1: A corner piece in the dengue pathogenesis puzzle? Sci. Transl. Med. 7: 304fs37.
43. Modhiran, N., D. Watterson, D. A. Muller, A. K. Panetta, D. P. Sester, L. Liu, D. A. Hume, K. J. Stacey, and P. R. Young. 2015. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7: 304ra142.
44. Beatty, P. R., H. Puerta-Guardo, S. S. Killingbeck, D. R. Glasner, K. Hopkins, and E. Harris. 2015. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7: 304ra141.
45. Lam, J. H., L. C. Ong, and S. Alonso. 2015. Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates? Expert Rev. Vaccines 28: 1-13.
46. Halstead, S. B. 2013. Identifying protective dengue vaccines: guide to mastering an empirical process. Vaccine 31: 4501-4507.
47. Wan, S. W., C. F. Lin, S. Wang, Y. H. Chen, T. M. Yeh, H. S. Liu, R. Anderson, and Y. S. Lin. 2013. Current progress in dengue vaccines. J. Biomed. Sci. 20: 37.